Liquidia Corporation

NASDAQ (USD): Liquidia Corporation (LQDA)

Last Price

12.39

Today's Change

-0.07 (0.56%)

Day's Change

12.27 - 12.47

Trading Volume

76,546

Profile
LQDA

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Roger A. Jeffs Ph.D. Dr. Roger A. Jeffs Ph.D.

Full Time Employees:  145 145

IPO Date:  2018-07-26 2018-07-26

CIK:  0001819576 0001819576

ISIN:  US53635D2027 US53635D2027

CUSIP:  53635D202 53635D202

Beta:  0.20 0.20

Last Dividend:  0.00 0.00

Dcf Diff:  23.58 23.58

Dcf:  -11.12 -11.12

Description

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Address

419 Davis Drive,
Morrisville, NC 27560, US

919 328 4400

http://www.liquidia.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment